CIK 1274403
ARCH Venture Management, LLC
Institutional 13F holdings & portfolio
Holdings
9
Portfolio Value
$1M+
Latest Report
Sep 30, 2025
Report Periods
2
Holdings
13F filings as of Sep 30, 2025 · Showing 1–9 of 9
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| RAPP | RAPPORT THERAPEUTICS INC. | 3.7M | $1M+ | SH |
| BEAM | BEAM THERAPEUTICS INC. | 4.5M | $1M+ | SH |
| MAZE | MAZE THERAPEUTICS INC. | 4.1M | $1M+ | SH |
| VIR | VIR BIOTECHNOLOGY INC. | 12.9M | $1M+ | SH |
| — | LYELL IMMUNOPHARMA INC. | 2.8M | $1M+ | SH |
| ERAS | ERASCA INC. | 11.1M | $1M+ | SH |
| GOSS | GOSSAMER BIO INC. | 8.1M | $1M+ | SH |
| QTTB | Q32 BIO INC. | 320K | $500K+ | SH |
| CERO | CERO THERAPEUTICS HOLDINGS INC. | 22K | $100K–$500K | SH |